A Rapid and Effective Tool for Monitoring Monoclonal Antibody Production
Poster Aug 13, 2014
B. Bhullar, Ph.D., Carlina Hui, B.Sc., M. Hariharan, M.Sc., J. Hewitt, B.Sc , and N. Vats, Ph.D.
IVD manufacturers must establish QC systems to assure that the product received is suitable for use. As an alternative to laborious time consuming conventional methods such as ELISA or dot immunobinding, we examined the effectiveness and utility of rapid point-of-use immuoanalytical tools created with MedMira's MiriadTM RVF Toolkit to quickly assess the suitability of hybridoma bioreactor supernatants.